scholarly journals Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada

2019 ◽  
Vol 26 (4) ◽  
Author(s):  
P. Hawley ◽  
M. Gobbo
Keyword(s):  
Health Care ◽  
Adverse Effects ◽  
Cancer Patients ◽  
Health Care Professional ◽  
Cannabis Use ◽  
Routes Of Administration ◽  
The Past ◽  
Current State ◽  
Patients Experience ◽  
Multiple Symptoms

Background Cancer patients experience multiple symptoms throughout their illness, and some report benefit from the use of cannabis. There are concerns that many patients are accessing products inappropriate for their situation and potentially putting themselves at risk. In the present study, we aimed to capture the prevalence of cannabis use among cancer patients at BC Cancer before recreational legalization in Canada and to identify the reasons that patients take cannabis, the various routes of administration they use, and the reasons that prior users stopped.Methods Patients were eligible if, on the selected study day (15 August 2018), they were scheduled for an appointment at any of the 6 BC Cancer sites. Eligible patients were mailed a survey.Results Of surveys sent to 2998 patients, 821 (27.4%) were returned and included in analysis. Of those respondents, 23% were currently using cannabis-based products, almost exclusively for medical purposes, and an additional 28% had been users in the past (most often recreationally). Of the patients currently using cannabis, 31% had medical authorization. The most common symptoms that the current users were targeting were pain, insomnia, nausea, and anxiety; many were also hoping for anticancer effects.Conclusions More than half the respondents had tried cannabis at some time, and almost one quarter of respondents were currently taking cannabis to help manage their symptoms or treat their cancer, or both. Many more patients would consider use with appropriate guidance from a health care professional. More research is needed to inform physicians and patients about safe uses and doses and about the potential adverse effects of cannabis use.

scholarly journals Evaluating Metrics Applied to the Medical Science Liaison (MSL) Role: A Survey-Based Study of Canadian MSL Leaders

2021 ◽  
Author(s):  
Munaza Saleem ◽  
Lisa Cesario ◽  
Lisa Wilcox ◽  
Marsha Haynes ◽  
Simon Collin ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Professional ◽  
Online Survey ◽  
Medical Science ◽  
Specialty Care ◽  
Product Lifecycle ◽  
The Past ◽  
Data Analyses ◽  
Quantitative Metrics ◽  
Frequency Of Use

Abstract Introduction Metrics utilized within the Medical Science Liaison (MSL) role are plentiful and traditionally quantitative. We sought to understand the current use and value of metrics applied to the MSL role, including the use of qualitative metrics. Methods We developed a list of 70 MSL leaders working in Canada, spanning 29 companies. Invitations were emailed Jun 16, 2020 and the 25-question online survey was open for 3 weeks. Questions were designed to assess demographics as well as how and why metrics are applied to the MSL role. Data analyses were descriptive. Results Responses were received from 44 leaders (63%). Of the 42 eligible, 45% had ≤ 2 years of experience as MSL leaders and 86% supported specialty care products over many phases of the product lifecycle. A majority (69%) agreed or strongly agreed that metrics are critical to understanding whether an MSL is delivering value, and 98% had used metrics in the past year. The most common reason to use metrics was ‘to show value/impact of MSLs to leadership’ (66%). The most frequently used metric was ‘number of health-care professional (HCP) interactions’, despite this being seen as having moderate value. Quantitative metrics were used more often than qualitative, although qualitative were more often highly valued. Conclusion The data collected show a lack of agreement between the frequency of use for some metrics and their value in demonstrating the contribution of an MSL. Overall, MSL leaders in our study felt qualitative metrics were a better means of showing the true impact of MSLs.

Handoff Research

2016 ◽  
Vol 5 (1) ◽  
pp. 106-111 ◽  
Author(s):  
Lee Ann Riesenberg ◽  
Robyn Davis ◽  
Emma O’Hagan
Keyword(s):  
Health Care ◽  
Medical Students ◽  
Nursing Students ◽  
Health Care Providers ◽  
Medical Errors ◽  
Complex Task ◽  
Care Providers ◽  
The Past ◽  
Current State ◽  
And Training

Handoffs, or the transfer of patient care from one provider to another, are a complex task which can both contribute to and prevent medical errors. In this article, we review three topics that illustrate what is good, bad, and ugly about the current state of handoff research. First, we examine the good, the increase both in quantity and variety of research into patient handoffs over the past 30 years. Second, we discuss what is lacking, funding for handoff research. Finally we review one of the most troubling aspects of handoffs, the general lack of education and training for medical students, residents, and nursing students, to prepare them to manage handoffs as health care providers.

Colorectal cancer patients’ informational needs about sexuality related issues

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 18569-18569 ◽  
Author(s):  
S. Karagiannis ◽  
P. Heras ◽  
A. Hatzopoulos ◽  
A. Georgopoulou ◽  
K. Kritikos
Keyword(s):  
Colorectal Cancer ◽  
Health Care ◽  
Adverse Effects ◽  
Cancer Patients ◽  
Health Care Professionals ◽  
Health Care Personnel ◽  
Informational Needs ◽  
Action Models ◽  
Colorectal Cancer Patients ◽  
Sensitive Issues

18569 The aim of this study was to identify and describe the importance of information for patients about sexuality related issues during hospitalization. 112 patients (87 with colorectal cancer) completed the structural questionnaire. Most colorectal cancer patients (71%) reported that their disease or its treatment had affected their sexuality. Men reported slightly more adverse effects of disease or treatment on their sexuality than did women. Effects on sexuality were reported by 77% of men and 64% of women (p=0,041) having colorectal cancer. Among younger colorectal cancer patients reported more often effects of disease than did older colorectal cancer respondents. Over than half, 75% (n=84) of respondents under 40 and 67% (n= 75) of respondents over 50 years old complained effect on sexuality. Most colorectal cancer patients (72%) stated that it is necessary to discuss about the effect of the disease and of its treatment on sexuality during hospitalization. Most colorectal cancer patients (87%) wanted the health care personnel to take the initiative for the discussion of sexuality related issues. Only 12% expressed the wish that the initiative should come from the patient. It is important that health care professionals provide colorectal cancer patients with an opportunity to discuss sexuality related issues. The caring organization should develop, introduce and evaluate action models to facilitate especially opening discussion for these sensitive issues. No significant financial relationships to disclose.

scholarly journals Treatment of Nausea and Vomiting During Chemotherapy

2011 ◽  
Vol 07 (02) ◽  
pp. 91 ◽  
Author(s):  
Karen M Mustian ◽  
Katie Devine ◽  
Julie L Ryan ◽  
Michelle C Janelsins ◽  
Lisa K Sprod ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Cancer Patients ◽  
Nausea And Vomiting ◽  
Delayed Nausea ◽  
Patients Experience ◽  
Recommended Guidelines

Nausea and vomiting are two of the most troubling adverse effects patients experience during chemotherapy. While newly available treatments have improved our ability to manage nausea and vomiting, anticipatory and delayed nausea and vomiting are still a major problem for patients receiving chemotherapy. Many cancer patients will delay or refuse future chemotherapy treatments and contemplate stopping chemotherapy altogether because of their fear of experiencing further nausea and vomiting. The purpose of this article is to provide an overview of the patho-psychophysiology of chemotherapy-induced nausea and vomiting and the recommended guidelines for treatment.

scholarly journals Frequency of cannabis use and alcohol-associated adverse effects in a representative sample of U.S. adolescents and youth (2002–2014) a cross-sectional study

2020 ◽  
Vol 2 (1) ◽  
Author(s):  
Majed M. Ramadan ◽  
Jim E. Banta ◽  
Khaled Bahjri ◽  
Susanne B. Montgomery
Keyword(s):  
Alcohol Use ◽  
Adverse Effects ◽  
Alcohol Dependence ◽  
Heavy Drinking ◽  
Interpersonal Problems ◽  
Risky Behaviors ◽  
Cannabis Use ◽  
Cross Sectional ◽  
The Past ◽  
Frequent Use

Abstract Background While the link between frequent cannabis use and alcohol use disorders is well documented, it is not clear whether alcohol drinkers who use cannabis less frequently are also vulnerable to alcohol use disorders. We estimate the association of frequency of past 12-months cannabis use with alcohol-associated adverse effects variables in the same time frame: alcohol dependence, heavy drinking, driving under alcohol influence, alcohol-related interpersonal problems, use after interpersonal problems, alcohol-related risky behaviors, and alcohol-related legal problems. Methods We analyzed data from U.S. individuals aged 12 to 25 years who participated in annual, cross-sectional U.S. National Surveys on Drug Use and Health from 2002 to 2014. Logistic regression models were used to examine the association of cannabis use with six alcohol-associated adverse effects variables. Frequency of cannabis use served as the primary independent variable, and were divided into four categories: frequent use (21–30 days per month), less frequent use (1–20 days per month), no use over the past 12 months, and no lifetime cannabis use. Alcohol dependence and six alcohol-associated adverse effects variables served as our primary outcomes. Results The study included 465,090 respondents aged 12 to 25 years, among all past-year cannabis users, (47.5%) were less frequent (1–20 days/month) users. Less frequent cannabis use was highest among male, 15–25-year-olds, and non-Hispanic white 11.8, 84 and 10.6%, respectively. In adjusted models, past-year less frequent cannabis use (1–20 days/month) was significantly associated with past-year alcohol dependence (adjusted odds ratio aOR 5.57, 95% confidence interval (CI) 5.5–6.4); heavy drinking in the past-year (aOR 3.41, 95% CI 3.2–3.5); alcohol-related interpersonal problems in the past-year (aOR 7.33, 95% CI 7.0–7.5); use after interpersonal problems (aOR 5.17, 95% CI 4.8–5.5); alcohol-related risky behaviors (aOR 7.29, 95% CI 7.0–7.5), and, driving under influence of alcohol (aOR 7.19, 95% CI 6.9–7.4). No cannabis use past-year were more likely to report alcohol dependence (aOR 2.81, 95% CI 2.6–3) compared with no lifetime cannabis use. Conclusion These findings indicated that within the general population, not only frequent cannabis user (21–30 days per month) but even less frequent cannabis use (1–20 days/month) was significantly associated with past-year alcohol dependence and alcohol-associated adverse effects than no lifetime cannabis use. These adverse alcohol-related outcomes associated with less frequent cannabis use, should be taken under careful consideration in alcohol use disorder treatment setting and policy planning.

Sign in / Sign up

Export Citation Format

Share Document